- A study looked at Alzheimer’s tests across many people.
- Tests may not show the same brain changes.
- The difference can be for women and men.
- Many people with Alzheimer’s are women.
- A good test score can be misleading for some women.
- Men's brains can change earlier in the disease.
- Women's brains can decline later and faster.
- Doctors should use sex-aware methods to judge tests.
- Stay mentally and physically active for prevention.
- Talk with a doctor about family history and risk.
Difficult words
- misleading — giving a wrong idea or impression
- decline — become worse or lower over time
- prevention — actions to stop a disease happening
- risk — chance that something bad will happen
- sex-aware — considering differences between women and men
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Have you talked with a doctor about family history and risk?
- Do you do mental or physical activities to stay healthy?
- Do you think tests always show brain changes?
Related articles
Vigorous exercise helps sleep in older adults with mild cognitive impairment
A small Texas A&M study used Oura Rings to track seven older adults with mild cognitive impairment for 14 days. Vigorous exercise gave the largest sleep benefit; light activity helped a little and moderate exercise showed no clear effect.
Many pesticides used in Latin America are banned in the EU
A study found that many active pesticide ingredients allowed on major crops in eight Latin American countries are banned or not authorised in the EU. The researchers examined public approval records up to December 2020 and warn of health risks.
Targeting inflammation as a way to treat depression
A federally funded review and meta-analysis found that anti-inflammatory treatments reduced depressive symptoms and eased anhedonia in people with depression who had high inflammation. The drugs were not FDA-approved for depression and would be used off-label.
Protein sensor lets MRI detect molecular activity
Researchers developed a genetically encoded protein sensor, called MAPPER, that makes molecular activity visible to MRI by changing water movement in cells. The modular system could let scientists image processes like cancer and inflammation continuously in animals.